The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Alternative Activation of STAT1 and STAT3 in Response to Interferon-γ
Open accessAbstract
Interferon-gamma (IFNgamma) is a pluripotent cytokine whose major biological effects are mediated through a pathway in which STAT1 is the predominant and essential transcription factor. STAT3 can also be activated weakly by IFNgamma, but the mechanism of activation and function of STAT3 as a part of the interferon response are not known. Here we show that STAT3 activation is much stronger and more prolonged in STAT1-null mouse embryo fibroblasts than in wild-type cells. In response to IFNgamma, SRC-family kinases are required to activate STAT3 (but not STAT1) through tyrosine phosphorylation, whereas the receptor-bound kinases JAK1 and JAK2 are required to activate both STATs. Tyrosine 419 of the IFNgamma receptor subunit 1 (IFNGR1) is required to activate both STATs, suggesting that STAT1 and STAT3 compete with each other for the same receptor phosphotyrosine motif. Activated STAT3 can replace STAT1 in STAT1-null cells to drive the transcription of certain genes, for example, socs-3 and c/ebpdelta, which have gamma-activated sequence motifs in their promoters. Work from Ian Kerr's laboratory reveals that the gp130-linked interleukin-6 receptor, which usually activates STAT3 predominantly, activates STAT1 efficiently when STAT3 is absent. Because STAT1 and STAT3 have opposing biological effects (STAT3 is an oncogene, and STAT1 is a tumor suppressor), the reciprocal activation of these two transcription factors in response to IFNgamma or interleukin-6 suggests that their relative abundance, which may vary substantially in different normal cell types, under different conditions or in tumors is likely to have a major impact on how cells behave in response to different cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Self-citationSTATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,242
THE IFNγ RECEPTOR:A Paradigm for Cytokine Receptor Signaling
Bach, E. A., Aguet, M., & Schreiber, R. D. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.563 · Cited by 1,034
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Jaks and Stats in signaling by the cytokine receptor superfamily
Ihle, J. N., & Kerr, I. M. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89000-9 · Cited by 898
Src family kinases in tumor progression and metastasis
Summy, J. M., & Gallick, G. E. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023772912750 · Cited by 827
Bromberg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15617 · Cited by 770
Chin, Y. E., Kitagawa, M., Su, W.-C. S., You, Z.-H., Iwamoto, Y., & Fu, X.-Y. (1996) · Science · doi:10.1126/science.272.5262.719 · Cited by 696
STAT proteins: From normal control of cellular events to tumorigenesis
Calò, V., Migliavacca, M., Bazan, V., Macaluso, M., Buscemi, M., Gebbia, N., & Russo, A. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10364 · Cited by 610
SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling
Blake, R. A., Broome, M. A., Liu, X., Wu, J., Gishizky, M., Sun, L., & Courtneidge, S. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.9018-9027.2000 · Cited by 584
Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M., & Hirano, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00734.x · Cited by 565
Stat1-dependent and -independent pathways in IFN-γ-dependent signaling
Ramana, C. V., Gil, M. P., Schreiber, R. D., & Stark, G. R. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02118-4 · Cited by 555
Self-citationA STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain.
Horvath, C. M., Wen, Z., & Darnell, J. E. (1995) · Genes & Development · doi:10.1101/gad.9.8.984 · Cited by 533
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M., Irby, R., Yeatman, T., Courtneidge, S. A., & Jove, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131568898 · Cited by 488
Bromberg, J. F., Horvath, C. M., Wen, Z., Schreiber, R. D., & Darnell, J. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7673 · Cited by 422
Seidel, H. M., Milocco, L. H., Lamb, P., Darnell, J. E., Stein, R. B., & Rosen, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.3041 · Cited by 415
Goh, K. C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5601 · Cited by 379
Biologic consequences of Stat1-independent IFN signaling
Gil, M. P., Bohn, E., O'Guin, A. K., Ramana, C. V., Levine, B., Stark, G. R., Virgin, H. W., & Schreiber, R. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111163898 · Cited by 344
Self-citationRegulation of c-myc expression by IFN-γ through Stat1-dependent and -independent pathways
Ramana, C. V., Grammatikakis, N., Chernov, M., Nguyen, H., Chuan Goh, K., Williams, B. R. G., & Stark, G. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.2.263 · Cited by 319
Self-citationGreenlund, A. C., Morales, M. O., Viviano, B. L., Yan, H., Krolewski, J., & Schreiber, R. D. (1995) · Immunity · doi:10.1016/1074-7613(95)90012-8 · Cited by 304
Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox
Nguyen, K. B., Cousens, L. P., Doughty, L. A., Pien, G. C., Durbin, J. E., & Biron, C. A. (2000) · Nature Immunology · doi:10.1038/76940 · Cited by 303
Auernhammer, C. J., Bousquet, C., & Melmed, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6964 · Cited by 284
Mutational switch of an IL-6 response to an interferon-γ-like response
Costa-Pereira, A. P., Tininini, S., Strobl, B., Alonzi, T., Schlaak, J. F., Is'harc, H., Gesualdo, I., Newman, S. J., Kerr, I. M., & Poli, V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122236099 · Cited by 264
Shen, Y., Devgan, G., Darnell, J. E., & Bromberg, J. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1543 · Cited by 249
Nguyen, H., Ramana, C. V., Bayes, J., & Stark, G. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105070200 · Cited by 247
Self-citationStat1-independent regulation of gene expression in response to IFN-γ
Ramana, C. V., Gil, M. P., Han, Y., Ransohoff, R. M., Schreiber, R. D., & Stark, G. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111164198 · Cited by 243
Self-citationJAKs, STATs and Src kinases in hematopoiesis
Rane, S. G., & Reddy, E. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205398 · Cited by 242
Hemmann, U., Gerhartz, C., Heesel, B., Sasse, J., Kurapkat, G., Grötzinger, J., Wollmer, A., Zhong, Z., Darnell, J. E., Graeve, L., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12999 · Cited by 239
IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled
Reddy, E. P., Korapati, A., Chaturvedi, P., & Rane, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203594 · Cited by 226
Series Introduction: JAK-STAT signaling in human disease
Schindler, C. W. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15644 · Cited by 218
In vitro activation of Stat3 by epidermal growth factor receptor kinase
Park, O. K., Schaefer, T. S., & Nathans, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13704 · Cited by 201
Series Introduction: JAK-STAT signaling in human disease
Schindler, C. W. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215644 · Cited by 198
Korzus, E., Nagase, H., Rydell, R., & Travis, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1188 · Cited by 170
Interleukin-6-Specific Activation of the C/EBPδ Gene in Hepatocytes Is Mediated by Stat3 and Sp1
Cantwell, C. A., Sterneck, E., & Johnson, P. F. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2108 · Cited by 162
Shuai, K., Liao, J., & Song, M. M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4932 · Cited by 158
Reprogramming of IL-10 Activity and Signaling by IFN-γ
Herrero, C., Hu, X., Li, W. P., Samuels, S., Sharif, M. N., Kotenko, S. V., & Ivashkiv, L. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5034 · Cited by 153
JAK-STAT signaling activated by Abl oncogenes
Danial, N. N., & Rothman, P. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203484 · Cited by 143
Kortylewski, M., Heinrich, P. C., Mackiewicz, A. A., Schniertshauer, U., Klingmüller, U., Nakajima, K., Hirano, T., Horn, F., & Behrmann, I. (1999) · Oncogene · doi:10.1038/sj.onc.1202708 · Cited by 135
Takaoka, A., Tanaka, N., Mitani, Y., Miyazaki, T., Fujii, H., Sato, M., Kovarik, P., Decker, T., Schlessinger, J., & Taniguchi, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2480 · Cited by 133
Activation of Protein Kinase Cδ by IFN-γ
Deb, D. K., Sassano, A., Lekmine, F., Majchrzak, B., Verma, A., Kambhampati, S., Shahab Uddin, M. S., Rahman, A., Fish, E. N., & Platanias, L. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.267 · Cited by 127
Kincaid, E., & Ernst, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.2042 · Cited by 115
Lee, D., Carrasco, J., Hidalgo, J., & Andrews, G. K. (1998) · Biochemical Journal · doi:10.1042/0264-6021:3370059 · Cited by 106
Hemmi, S., Peghini, P. L., Metzler, M., Merlin, G., Dembić, Z., & Aguet, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9901 · Cited by 102
An Essential Role for Daxx in the Inhibition of B Lymphopoiesis by Type I Interferons
Góngora, R., Stephan, R. P., Zhang, Z., & Cooper, M. D. (2001) · Immunity · doi:10.1016/s1074-7613(01)00152-2 · Cited by 95
Interferon-γ-induced Epithelial ICAM-1 Expression and Monocyte Adhesion
Chang, Y., Holtzman, M. J., & Chen, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109924200 · Cited by 94
Of JAKs, STATs, blind watchmakers, jeeps and trains
Kerr, I. M., Costa‐Pereira, A. P., Lillemeier, B. F., & Strobl, B. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00411-3 · Cited by 84
Activation of STAT3 by the c-Fes Protein-tyrosine Kinase
Nelson, K. L., Rogers, J. A., Bowman, T. L., Jove, R., & Smithgall, T. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.7072 · Cited by 75
Vignais, M., & Gilman, M. Z. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3727 · Cited by 71
Cloning and characterization of a functional promoter of the human SOCS-3 gene
He, B., You, L., Uematsu, K., Matsangou, M., Xu, Z., He, M., McCormick, F. P., & Jablons, D. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03071-1 · Cited by 68
Wiederkehr-Adam, M., Ernst, P., Müller, K., Bieck, E., Gombert, F. O., Ottl, J., Graff, P., Grossmüller, F., & Heim, M. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300261200 · Cited by 62
Inhibitor of κB kinase is required to activate a subset of interferon γ-stimulated genes
Sizemore, N., Agarwal, A., Das, K., Lerner, N., Sulak, M. A., Rani, S., Ransohoff, R. M., Shultz, D. B., & Stark, G. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401593101 · Cited by 58
Self-citationWang, J., Schreiber, R. D., & Campbell, I. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252454799 · Cited by 58
Choudhury, G. G., Ghosh‐Choudhury, N., & Abboud, H. E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1044 · Cited by 55
Woldman, I., Varinou, L., Ramsauer, K., Rapp, B., & Decker, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105320200 · Cited by 35
Stat-1 Is Not Essential for Inhibition of B Lymphopoiesis by Type I IFNs
Góngora, R., Stephan, R. P., Schreiber, R. D., & Cooper, M. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2362 · Cited by 33
SOCS Proteins: Modulators of Neuroimmunoendocrine Functions: Impact on Corticotroph LIF Signaling
Auernhammer, C. J., Bousquet, C., Chesnokova, V., & Melmed, S. K. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05431.x · Cited by 19
Cited by
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Garcia-Diaz, A., Shin, D. S., Moreno, B. H., Saco, J., Escuin-Ordinas, H., Rodriguez, G. A., Zaretsky, J. M., Sun, L., Hugo, W., Wang, X., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.031 · Cited by 1,942
Mechanisms and consequences of Jak–STAT signaling in the immune system
Villarino, A. V., Kanno, Y., & O'Shea, J. J. (2017) · Nature Immunology · doi:10.1038/ni.3691 · Cited by 1,221
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224
The JAK-STAT Signaling Pathway: Input and Output Integration
Murray, P. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2623 · Cited by 1,179
Interferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154
Self-citation
Metadata
- Authors
- Qing, Y., & Stark, G. R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-10
- Volume
- 279
- Issue
- 40
- Pages
- 41679-41685
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2075325752
- Cited by
- 316
- References
- 65
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.